swish30

ATNM - Potential bottom reversal

看多
AMEX:ATNM   Actinium Pharmaceuticals, Inc. (Delaware)
Insiders bought recently before the offering at $1.10 per share. Slightly risky when Actimab-A Phase 2 results could come out anytime.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。